Inotiv, Inc.
NOTV • NASDAQ
Inotiv, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Robert W. Leasure Jr., with a market cap of $13.4M.
CEORobert W. Leasure Jr.
Market Cap$13.4M
Medical - Diagnostics & Research
Healthcare
Employees2.1K
Websiteinotivco.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Inotiv, Inc.
Date
Wednesday, May 6, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.55
Revenue Estimate
$131.2M
Earnings History
Past 11 earnings reports for Inotiv, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Dec 3, 2025 | Q4 2025 | -$0.25Est: -$0.08 | -212.5% | $138.1MEst: $137.5M | +0.5% |  10-K/A |
| Aug 6, 2025 | Q3 2025 | -$0.51Est: -$0.15 | -240.0% | $130.7MEst: $126.0M | +3.7% | 10-Q |
| May 7, 2025 | Q2 2025 | -$0.44Est: -$0.23 | -91.3% | $124.3MEst: $126.8M | -1.9% | 10-Q |
| Feb 5, 2025 | Q1 2025 | -$1.02Est: -$0.42 | -142.9% | $119.9MEst: $121.8M | -1.6% | 10-Q |
| Dec 3, 2024 | Q4 2024 | -$0.73 | — | $130.4MEst: $116.9M | +11.5% | 10-K |
| Aug 8, 2024 | Q3 2024 | -$1.00Est: -$0.83 | -20.5% | $105.8MEst: $123.4M | -14.3% | 10-Q |
| May 15, 2024 | Q2 2024 | -$0.83Est: -$0.54 | -53.7% | $119.0MEst: $135.7M | -12.3% | 10-Q/A |
| Feb 7, 2024 | Q1 2024 | -$0.60Est: -$0.85 | +29.4% | $135.5MEst: $132.9M | +2.0% | 10-Q |
| Dec 11, 2023 | Q4 2023 | -$0.38Est: -$0.33 | -15.2% | $140.7MEst: $139.4M | +0.9% | — |
| Aug 10, 2023 | Q3 2023 | $0.07Est: -$0.10 | +170.0% | $157.5MEst: $151.1M | +4.2% | — |
| May 11, 2023 | Q2 2023 | -$0.39Est: -$0.42 | +7.1% | $151.5MEst: $133.3M | +13.6% | — |